Basic information Safety Supplier Related

H-TRP-GLU-OH

Basic information Safety Supplier Related

H-TRP-GLU-OH Basic information

Product Name:
H-TRP-GLU-OH
Synonyms:
  • TRP-GLU
  • H-TRP-GLU-OH
  • L-TRYPTOPHYL-L-GLUTAMIC ACID
  • L-TRP-GLU
  • TRP-GLU CRYSTALLINE
  • G3335
  • PPARγ Antagonist III,G3335
  • WE
CAS:
36099-95-3
MF:
C16H19N3O5
MW:
333.34
Product Categories:
  • A cell-permeable dipeptide that acts as a selective and reversible PPAR./ antagonist
  • Amino Acid Derivatives
Mol File:
36099-95-3.mol
More
Less

H-TRP-GLU-OH Chemical Properties

Melting point:
>163°C(dec.)
Boiling point:
720.7±60.0 °C(Predicted)
Density 
1.428±0.06 g/cm3(Predicted)
storage temp. 
-15°C
solubility 
Chloroform (Slightly), DMSO (Slightly)
form 
White solid
pka
3.02±0.10(Predicted)
color 
white to off-white
Sensitive 
Light Sensitive
More
Less

H-TRP-GLU-OH Usage And Synthesis

Uses

A cell-permeable dipeptide that acts as a selective and reversible peroxisome proliferator-activated receptor antagonist

Definition

ChEBI: Trp-Glu is a dipeptide formed from L-tryptophan and L-glutamic acid residues. It has a role as a metabolite.

Biological Activity

kd = 8.34 μmg3335 is a pparγ antagonist.the peroxisome proliferator-activated receptor gamma (ppargamma) is a key therapeutic drug target for several conditions, such as inflammation, diabetes, hypertension, dyslipidemia, and cancer.

in vitro

biacore 3000 study based on the surface plasmon resonance technique found that g3335 exhibited a highly specific binding affinity against ppargamma and was able to block rosiglitazone, a potent ppargamma agonist, in the stimulation of the interaction between the ppargamma ligand-binding domain (lbd) and rxralpha-lbd. moreover, the yeast two-hybrid assays indicated that g3335 had strong antagonistic activity in perturbing rosiglitazone in the promotion of the ppargamma-lbd-cbp interaction. in addition, g3335 could competitively bind to ppargamma against 0.1 microm rosiglitazone to repress reporter-gene expression [1].

in vivo

in a previous study, the effect of rosiglitazone was examined on spinal cord injury (sci) in rats. the animals were randomly divided into vehicle group, rosiglitazone treated group, and g3335 treated group. locomotor function recovery was evaluated. results showed that compared with the vehicle groups, the rosiglitazone could significantly ameliorate locomotor recovery, reduce nf-κb expression, and increase the proliferation of endogenous npcs. in addition, when the ppar-γ antagonist g3335 was applied, such effects were abolished [2].

References

[1] ye, f. ,zhang, z.s.,luo, h.b., et al. the dipeptide h-trp-glu-oh shows highly antagonistic activity against pparγ: bioassay with molecular modeling simulation. chembiochem 7, 74-82 (2006).
[2] meng, q. q.,liang, x.j.,wang, p., et al. rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. neuroscience letters 503, 191-195 (2011).

H-TRP-GLU-OHSupplier

GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com
VDM Biochemicals
Tel
0330-2528181
Email
sales@vdmbio.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com